Physician profile
Jatinder Bansal
NPI 1578659322
$234.30
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $59.67 · 2022: $74.63 · 2023: $85.43 · 2024: $14.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $73.43 · Entertainment: $26.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $73.43 |
| Entertainment | $26.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $74.63 | 2022 | |
| Alcon Vision LLC | $37.60 | 2020-2024 | Dailies Total1 |
| Optos, INC. | $26.57 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $21.10 | 2023 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $20.19 | 2023 | Lipiflow System Activator (Disposable) |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Abbvie INC. | $17.57 | 2023 | Vuity |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jatinder Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.